Walpar Nutritions logo

Walpar Nutritions

WALPAR NSE
₹26.10 0.00 (0.00%)
Market Cap
₹24.51 Cr

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹24.51 Cr
EBITDA
₹6.90 Cr
Return on Equity
14.48%
Debt to Equity
0.89
Book Value
₹20.13
EPS (TTM)
—
52W High
₹50.60
52W Low
₹21.25

Price-based figures as of 13 Oct 2026, 12:03 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,770.7035.134,24,850 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,285.0084.272,46,488 Cr14.710.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,642.9072.891,76,601 Cr21.000.82%12.16%9.06%15,391 Cr2,156 Cr
Zydus Life Science
₹1,132.5025.201,12,967 Cr4.170.09%16.99%19.24%28,515 Cr4,593 Cr
Laurus Labs
₹2,059.40101.751,11,272 Cr21.000.10%16.38%19.67%7,323 Cr1,090 Cr
Cipla
₹1,329.6031.851,07,413 Cr3.121.00%11.21%14.88%28,786 Cr3,356 Cr
Dr Reddys Laboratories
₹1,240.0032.121,03,500 Cr2.720.67%10.87%13.94%34,555 Cr3,184 Cr
Mankind Pharma
₹2,372.0047.9597,974 Cr6.010.04%11.70%13.78%15,074 Cr2,067 Cr
Aurobindo Pharma
₹1,684.6026.2896,928 Cr2.560.24%9.25%13.58%35,390 Cr3,711 Cr
Lupin
₹1,953.6016.1589,336 Cr3.980.92%23.79%28.42%30,017 Cr5,552 Cr
Walpar Nutritions (this company)
₹26.10—25 Cr1.300.00%14.48%15.78%——
Median 11 companies₹1,770.7033.631,07,413 Cr4.170.32%13.79%15.78%28,651 Cr3,270 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 13.7% over last 3 years.

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

BearishNeutralBullish

Bearish

Bearish
9
Neutral
7
Bullish
3

Moving Averages

BearishNeutralBullish

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
9.72% lower than 3Y

change over 1 year

Net Income Growth
14.29% lower than 3Y

change over 1 year

Cash Flow Change
-54.93%

change over 1 year

EBITDA Margin Change
5.29%

change over 1 year Operating margin 8.79% · Mar 2026

Quarterly Results

Particulars Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
13.98
13.98
12.78
16.52
18.62
31.14
31.38
32.53
39.24
36.49
42.3
Expenses
13.47
13.47
12.27
15.52
16.12
29.15
28.62
29.89
36.16
33.55
38.58
Operating Profit
0.51
0.51
0.51
1
2.5
1.99
2.76
2.64
3.08
2.94
3.72
OPM %
3.65%
3.65%
3.99%
6.05%
13.43%
6.39%
8.8%
8.12%
7.85%
8.06%
8.79%
Other Income
0.04
0.04
-0.02
0.05
0.27
0.06
0.16
0.31
-0.04
0.13
0.13
Interest
0.25
0.25
0.24
0.44
0.36
0.33
0.34
0.26
0.03
0.3
0.5
Depreciation
0.13
0.13
0.15
0.84
1.07
0.92
0.89
0.88
0.94
1
1.02
PBT
0.17
0.17
0.1
-0.23
1.34
0.8
1.69
1.81
2.07
1.77
2.33
Tax %
29.41%
29.41%
-130%
39.13%
15.67%
20%
23.08%
22.1%
32.85%
15.25%
27.04%
Net Profit
0.12
0.12
0.24
-0.33
1.14
0.65
1.29
1.41
1.39
1.5
1.5
EPS (₹)
0.19
0.14
0.27
-0.42
1.07
0.43
1.26
1.37
1.11
1.37
1.26
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
6.07
26.76
35.14
62.52
71.76
78.77
Expenses
5.61
25.74
31.65
57.77
66.04
72.11
Operating Profit
0.46
1.02
3.49
4.75
5.72
6.66
OPM %
7.58%
3.81%
9.93%
7.6%
7.97%
8.45%
Other Income
0
0.02
0.32
0.22
0.27
0.26
Interest
0.18
0.48
0.79
0.67
0.29
0.8
Depreciation
0.12
0.28
1.91
1.81
1.82
2.02
PBT
0.16
0.28
1.11
2.49
3.88
4.1
Tax %
6.25%
-32.14%
27.03%
22.09%
27.84%
21.71%
Net Profit
0.15
0.36
0.81
1.94
2.79
3
EPS (₹)
0.22
0.42
0.65
1.68
2.47
2.63
Div. Payout %
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.34
4.54
4.54
4.7
9.39
9.39
Reserves
1.44
6.45
7.17
9.49
7.17
9.51
Borrowings
7.49
7.25
10.3
8.3
7.85
16.77
Other Liabilities
5.73
9.85
12.29
14.67
22.98
30.4
Total Liabilities
18
28.09
34.3
37.16
47.39
66.07
Fixed Assets
1.7
2.01
10.13
10.2
10.65
12.21
CWIP
1.22
4.48
0.02
0.02
0.03
0.05
Investments
0
0.49
0.02
1.88
1.88
2.88
Other Assets
15.08
21.11
24.13
25.06
34.83
50.93
Total Assets
18
28.09
34.3
37.16
47.39
66.07
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.31
-1.08
1.1
5.35
4.06
1.83
Investing
-2.02
-6.14
-3.44
-3.61
-2.3
-6.57
Financing
2.95
6.71
2.42
-1.77
-0.68
8.08
Net Cash Flow
0.62
-0.51
0.07
-0.03
1.08
3.34
Free Cash Flow
-2.17
-4.92
-4.14
3.48
1.78
-1.76
CFO/OP
-67
-99
34
116
82
41
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
431
124
130
78.46
108
109
Inventory Days
369
103
129
67.15
67.85
93.74
Days Payable
455
135
144
72.94
109
136
Cash Conversion Cycle
344
92.41
114
72.67
67.07
66.09
Working Capital Days
316
61.65
87.87
43.55
42.17
40.68
ROCE %
—
4.85%
8.78%
12.75%
16.08%
14.84%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Walpar Nutritions insights

56 extracted metrics + investor summaries across FY21–FY26.

Log in — free

Shareholding Pattern

Promot.68.82%Others7.97%Public23.22%As ofMar 2026

Documents

Frequently Asked Questions about Walpar Nutritions

What does Walpar Nutritions Ltd do?
Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.[1]
Where is Walpar Nutritions Ltd (WALPAR) listed?
Walpar Nutritions Ltd trades as WALPAR on the NSE.
Which sector does Walpar Nutritions Ltd belong to?
Walpar Nutritions Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Walpar Nutritions Ltd?
Walpar Nutritions Ltd has a market capitalisation of ₹24.51 Cr as of 13 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Walpar Nutritions Ltd?
Over the last 52 weeks Walpar Nutritions Ltd has traded between ₹21.25 and ₹50.6 as of 13 Oct 2026.
What is the Return on Equity (ROE) of Walpar Nutritions Ltd?
Walpar Nutritions Ltd reported a return on equity of 14.48%. Its debt-to-equity ratio is 0.89.

Company Information

Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.[1]

Website walparnutritions.com
Listed 2021-07-13
Face Value ₹ 10
Shares Outstanding 93,90,440

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/WALPAR.md for Walpar Nutritions Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List